Results 231 to 240 of about 53,339 (246)
Some of the next articles are maybe not open access.

Open Exceptions: Why Does the Brazilian Health Regulatory Agency (ANVISA) Exempts RIA and Ex Post Reviews?

Journal of Benefit-Cost Analysis
In this article, we examine the evolving landscape of Regulatory Impact Assessment (RIA) decisions made by the National Health Regulatory Agency (Agência Nacional de Vigilância Sanitária [Anvisa]), a prominent federal agency leading RIA implementation in
Natasha Schmitt Caccia Salinas   +1 more
semanticscholar   +1 more source

Comparative Analysis of Analytical Method Validation Requirements Across ICH, USP, ChP and ANVISA: A Review

Journal of Pharmaceutical Research International
This comprehensive guide provides a detailed comparison of analytical method validation requirements across four major regulatory bodies: the International Council for Harmonisation (ICH), United States Pharmacopeia (USP), Chinese Pharmacopoeia (ChP ...
Selvaraja Elumalai   +2 more
semanticscholar   +1 more source

Processo de Desenvolvimento de Produtos em Tecnologias Assistivas: Uma abordagem para regularização pela ANVISA

The Academic Society Journal, 2019
O presente trabalho propõe uma guia para empreendedores que se aventuram na apertura de uma empresa de produtos de Tecnologias Assistivas (TA’s). O manuscrito fornece uma sequência de passos que visam a regularização da empresa e o registro ou cadastro ...
D. Ponce
semanticscholar   +1 more source

Access, Fairness and Affordability: Procedural Justice in NICE, Anvisa and Conitec

SSRN Electronic Journal, 2014
Everywhere, health care systems are making hard choices about medicines. These choices are sensitive, controversial and often result in litigation. For example, the recent report in the UK about the drug Tamiflu casts doubt on the efficacy of the treatment and its value for money to the public health system.
Ricardo Perlingeiro   +3 more
openaire   +2 more sources

OVERVIEW OF THE BRAZILIAN HEALTH REGULATORY AGENCY ON SANITARY SURVEILLANCE (ANVISA) ON GOVERNANCE AND CAPACITY BUILDING FUNDAMENTAL RIGHTS: LEGAL POLICY AND INTERNATIONAL HARMONIZATION SYSTEMS

, 2018
The research examines the relevant elementes inspiring the brazilian health legislation and exposes the principles and goals of public policies from the analysis of competencies, structure and regulatory roles assigned to ANVISA, the Brazilian Health ...
C. Nunes
semanticscholar   +1 more source

Adicionando informações estruturadas ao Bulário Eletrônico da ANVISA [Adding structured information to the ANVISA's "Bulario Eletronico"]

Brazilian Symposium on Information Systems, 2015
The Brazilian Ministry of Health and other related organizations are concerned with the issue of self-medication. Although these organizations warn about the risks of concomitantly using different drugs, they do not provide any tools to facilitate this ...
Joao Vitor F. da Silva   +2 more
semanticscholar   +1 more source

Internal Standards (IS) Monitoring in CROs: Anvisa Perspective

Bioanalysis, 2019
Gustavo Mendes Lima Santos   +1 more
openaire   +3 more sources

Typographic articulation in digital medicine inserts: a study on Anvisa’s Bulário Eletrônico [PDF]

open access: possibleProceedings of the 6th Information Design International Conference, 2014
Carla Galvão Spinillo   +1 more
openaire   +1 more source

ANVISA atualiza regras de pesquisa clínica

Brazilian Journal of Periodontology
Isso mesmo, no último dia 2 de dezembro foram publicadas no Diário Oficial da União (DOU) a Resolução1 ANVISA (Agência Nacional de Vigilância Sanitária) nº 945 e a Instrução Normativa2 nº 338, ambas de 29 de novembro de 2024. Na área da Saúde, a busca pelas melhores práticas passa pela disponibilidade de estudos clínicos que assegurem eficácia e ...
openaire   +1 more source

Home - About - Disclaimer - Privacy